Overview
C2M Securities
05/06/2021
Not Provided
$1,000
Equity - Preferred
Seed
RegA+
$1.00
$6,927,500
2016
Healthcare & Pharmaceuticals
Medtech
B2B
High
High
Balance Sheet
|
Cash and Cash Equivalents |
$1,266,883 |
|
Investment Securities |
$1,250,000 |
|
Accounts and Notes Receivable |
$0 |
|
Property, Plant and Equipment (PP&E) |
$748,602 |
| Total Assets |
$3,299,921 |
|
Accounts Payable & Accrued Liabilities |
$147,969 |
|
Long Term Debt |
$0 |
|
Total Liabilities |
$287,641 |
|
Total Stockholders' Equity |
$3,012,280 |
| Total Liabilities and Equity |
$3,299,921 |
Statement of Comprehensive Income Information
|
Total Revenues |
$0 |
|
Costs & Expenses Applicable to Rev |
$2,509,472 |
|
Depreciation and Amortization |
$43,679 |
| Net Income |
$-2,031,609 |
|
Earnings Per Share - Basic |
$0.00 |
|
Earnings Per Share - Diluted |
$0.00 |
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
